Serum concentrations of soluble Fas antigen and soluble Fas ligand in mother and newborn

2000 ◽  
Vol 263 (3) ◽  
pp. 108-110 ◽  
Author(s):  
H. Iwama ◽  
H. Akutsu ◽  
S. Kuretake ◽  
J. Tohma ◽  
N. Nakamura
Keyword(s):  
Fas Ligand ◽  
Serum Concentrations ◽  
Fas Antigen ◽  
Soluble Fas ◽  
Soluble Fas Antigen ◽  
Soluble Fas Ligand

Soluble Fas Antigen and Soluble Fas Ligand in Intrauterine Growth Restriction

Neonatology ◽  
2010 ◽  
Vol 97 (1) ◽  
pp. 31-35 ◽  
Author(s):  
Despina D. Briana ◽  
Stavroula Baka ◽  
Maria Boutsikou ◽  
Sofia Liosi ◽  
Venetia-Maria Vraila ◽  
...  
Keyword(s):  
Intrauterine Growth Restriction ◽  
Fas Ligand ◽  
Growth Restriction ◽  
Fas Antigen ◽  
Intrauterine Growth ◽  
Soluble Fas ◽  
Soluble Fas Antigen ◽  
Soluble Fas Ligand

Soluble Fas antigen and soluble Fas ligand in early neonatal life

2003 ◽  
Vol 75 (1-2) ◽  
pp. 1-7 ◽  
Author(s):  
Angeliki Sarandakou ◽  
Efthimia Protonotariou ◽  
Dimitrios Rizos ◽  
Lygeri Soubassi ◽  
Ariadni Malamitsi-Puchner
Keyword(s):  
Fas Ligand ◽  
Fas Antigen ◽  
Soluble Fas ◽  
Neonatal Life ◽  
Soluble Fas Antigen ◽  
Soluble Fas Ligand

Variations in the serum concentrations of soluble Fas and soluble Fas ligand in Vietnamese patients infected with hepatitis B virus

2004 ◽  
Vol 73 (2) ◽  
pp. 244-249 ◽  
Author(s):  
Le H. Song ◽  
Vu Q. Binh ◽  
Dinh N. Duy ◽  
Thomas C. Bock ◽  
Peter G. Kremsner ◽  
...  
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Fas Ligand ◽  
Serum Concentrations ◽  
Soluble Fas ◽  
B Virus ◽  
Soluble Fas Ligand

Soluble Fas ligand and neopterin in patients with systemic and cutaneous discoid lupus erythematosus

Pteridines ◽  
2000 ◽  
Vol 11 (3) ◽  
pp. 85-89
Author(s):  
Barbara Wirleitner ◽  
Elisabeth Kowald ◽  
Bernhard Widner ◽  
Ulrike Ortner ◽  
Gabriele Baier-Bitterlich ◽  
...  
Keyword(s):  
Immune System ◽  
Lupus Erythematosus ◽  
Fas Ligand ◽  
Discoid Lupus Erythematosus ◽  
Serum Concentrations ◽  
Systemic Lupus ◽  
Serum Samples ◽  
Soluble Fas ◽  
Soluble Fas Ligand ◽  
The Status

SummaryEvidence accumulates suggesting that the pathogenesis in systemic lupus erythematosus (SLE) is associated with modulations in the Fas/FasL system. Serum concentrations of soluble Fas ligand (sFasL) were found to be elevated in patients with SLE. In this study we wanted to determine the levels of sFasL and the status of immune activation - monitored by neopterin secretion - in patients with SLE and cutaneous discoid lupus erythematosus (CDLE). Sixty-five serum samples were assayed. We found elevated concentrations of sFasL in patients with SLE and CDLE. The levels of sFasL in COLE patients were significant lower compared to SLE patients. Neopterin concentrations in serum were found to be slightly increased in patients with CDLE. Compared to patients with SLE, activation of the immune system was significant lower in COLE. Taken together, we found d evated levels of sFasL in patients with SLE as well as CDLE, connected with ar activation of the immune system and thereby increased concentration of neopterin in serum.

Levels of soluble Fas ligand in myocarditis

1998 ◽  
Vol 82 (2) ◽  
pp. 246-248 ◽  
Author(s):  
Tetsuya Toyozaki ◽  
Michiaki Hiroe ◽  
Masato Tanaka ◽  
Shigekazu Nagata ◽  
Hidemi Ohwada ◽  
...  
Keyword(s):  
Fas Ligand ◽  
Soluble Fas ◽  
Soluble Fas Ligand

Soluble fas ligand levels during rejection after paediatric liver transplantation

1998 ◽  
Vol 28 ◽  
pp. 67
Author(s):  
N. Hadzic ◽  
M. Hussain ◽  
P. Cheeseman ◽  
R. Francavilla ◽  
G. Mieli-Vergani ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Fas Ligand ◽  
Soluble Fas ◽  
Soluble Fas Ligand ◽  
Paediatric Liver Transplantation

Soluble fas antigen in serum of cancer patients

1999 ◽  
Vol 127 (3) ◽  
pp. 296-298 ◽  
Author(s):  
S. G. Abbasova ◽  
N. E. Kushlinskii ◽  
A. N. Murashev ◽  
I. A. Kostanyan ◽  
M. N. Obusheva ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Fas Antigen ◽  
Soluble Fas ◽  
Soluble Fas Antigen
Sign in / Sign up

Export Citation Format

Share Document